Evoxac (Daiichi Sankyo Pharma Development)
Welcome to the PulseAid listing for the Evoxac drug offered from Daiichi Sankyo Pharma Development. This Cholinergic Muscarinic Agonists [MoA],Cholinergic Receptor Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Daiichi Sankyo Pharma Development |
NON-PROPRIETARY NAME: | cevimeline hydrochloride |
SUBSTANCE NAME: | CEVIMELINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cholinergic Muscarinic Agonists [MoA],Cholinergic Receptor Agonist [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2000-01-12 |
END MARKETING DATE: | 0000-00-00 |
Evoxac HUMAN PRESCRIPTION DRUG Details:
Item Description | Evoxac from Daiichi Sankyo Pharma Development |
LABELER NAME: | Daiichi Sankyo Pharma Development |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 30(mg/1) |
START MARKETING DATE: | 2000-01-12 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 63395-201_3e7f5395-9fff-44d8-b44e-2c0e2c182f70 |
PRODUCT NDC: | 63395-201 |
APPLICATION NUMBER: | NDA020989 |
Other CEVIMELINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: